Delivery Order SPE2DB25D3201-SPE2DB25FNNLS

Award Date 10/25/24
Potential Completion Date 10/28/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $41,031.57 firm fixed-price delivery order contract has a completion date of December 9, 2024. This award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $7,136.28. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 21, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $1,578.00 and is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
The federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,544.72 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, on November 6, 2024, with a completion date of November 7, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award is for the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML, with a ceiling value of $6,395.58. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 14, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, delivered under a delivery order with a fixed-price contract. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $37,104.27. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
This federal contract award is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,156.00. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running...
This federal contract award is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,052. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 9, 2024. This award is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $1,578.00 and a period of performance through August 12, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,519.67, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, with an ultimate completion date of November 13, 2024. The contract is not designated with a set-aside requirement, indicating...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNNLS
    Delivery Order

The federal contract award is for the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $3,991.12 and an ultimate completion date of October 28, 2024. The contract was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 1/24/25, 9:29 AM